122 related articles for article (PubMed ID: 8785475)
1. Digoxigenin-labeled phosphorothioate oligonucleotides: a new tool for the study of cellular uptake.
Tarrasón G; Bellido D; Eritja R; Vilaró S; Piulats J
Antisense Res Dev; 1995; 5(3):193-201. PubMed ID: 8785475
[TBL] [Abstract][Full Text] [Related]
2. Intracellular distribution of digoxigenin-labeled phosphorothioate oligonucleotides.
Tarrasón G; Bellido D; Eritja R; Vilaró S; Piulats J
Methods Enzymol; 2000; 313():257-68. PubMed ID: 10595360
[No Abstract] [Full Text] [Related]
3. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells.
Iversen PL; Zhu S; Meyer A; Zon G
Antisense Res Dev; 1992; 2(3):211-22. PubMed ID: 1490072
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
[TBL] [Abstract][Full Text] [Related]
5. Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.
Zhao Q; Temsamani J; Agrawal S
Antisense Res Dev; 1995; 5(3):185-92. PubMed ID: 8785474
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of antisense oligonucleotides.
Agrawal S; Temsamani J; Galbraith W; Tang J
Clin Pharmacokinet; 1995 Jan; 28(1):7-16. PubMed ID: 7712663
[TBL] [Abstract][Full Text] [Related]
7. Oligodeoxyribonucleotide phosphorothioate fluxes and localization in hematopoietic cells.
Marti G; Egan W; Noguchi P; Zon G; Matsukura M; Broder S
Antisense Res Dev; 1992; 2(1):27-39. PubMed ID: 1422084
[TBL] [Abstract][Full Text] [Related]
8. The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries.
Farrell CL; Bready JV; Kaufman SA; Qian YX; Burgess TL
Antisense Res Dev; 1995; 5(3):175-83. PubMed ID: 8785473
[TBL] [Abstract][Full Text] [Related]
9. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
Bennett CF; Chiang MY; Chan H; Shoemaker JE; Mirabelli CK
Mol Pharmacol; 1992 Jun; 41(6):1023-33. PubMed ID: 1352033
[TBL] [Abstract][Full Text] [Related]
10. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes.
Wingens M; van Hooijdonk CA; de Jongh GJ; Schalkwijk J; van Erp PE
Arch Dermatol Res; 1998 Mar; 290(3):119-25. PubMed ID: 9558486
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice.
Saijo Y; Perlaky L; Wang H; Busch H
Oncol Res; 1994; 6(6):243-9. PubMed ID: 7865900
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
[TBL] [Abstract][Full Text] [Related]
14. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.
Thierry AR; Dritschilo A
Nucleic Acids Res; 1992 Nov; 20(21):5691-8. PubMed ID: 1454532
[TBL] [Abstract][Full Text] [Related]
15. Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible.
Iversen PL; Crouse D; Zon G; Perry G
Antisense Res Dev; 1992; 2(3):223-33. PubMed ID: 1490073
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides.
Crooke RM; Graham MJ; Cooke ME; Crooke ST
J Pharmacol Exp Ther; 1995 Oct; 275(1):462-73. PubMed ID: 7562586
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake and degradation of phosphorothioate oligonucleotides by marine and freshwater ciliates.
Thomas LL; Price CM
Antisense Res Dev; 1992; 2(3):251-6. PubMed ID: 1490074
[TBL] [Abstract][Full Text] [Related]
18. Sequence dependency of the internalization and distribution of phosphorothioate oligonucleotides in vascular smooth muscle cells.
Etore F; Tenu JP; Teiger E; Adnot S; Lonchampt MO; Pirotzki E; Le Doan T
Biochem Pharmacol; 1998 May; 55(9):1465-73. PubMed ID: 10076539
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
20. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ
J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]